On April 17, 2025, Phio Pharmaceuticals dismissed BDO USA as its accounting firm and engaged Grant Thornton LLP for the fiscal year ending December 31, 2025. BDO's previous reports did not contain adverse opinions but noted doubts about the company's ability to continue as a going concern.